Frances E. Lennon

发表

Lung cancer—a fractal viewpoint

Gianguido C. Cianci, M. Vannier, Chin-Tu Chen, 2015, Nature Reviews Clinical Oncology.

Methylnaltrexone Potentiates the Anti-Angiogenic Effects of mTOR Inhibitors

R. Salgia, Frances E. Lennon, J. Garcia, 2010, Journal of angiogenesis research.

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology

S. Batra, Prakash Kulkarni, R. Salgia, 2019, Journal of clinical medicine.

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma

Ravi Salgia, Hedy L. Kindler, Rajani Kanteti, 2016, Scientific Reports.

Mitochondrial dynamics: biology and therapy in lung cancer

R. Salgia, Frances E. Lennon, 2014, Expert opinion on investigational drugs.

Transactivation of the Receptor-tyrosine Kinase Ephrin Receptor A2 Is Required for the Low Molecular Weight Hyaluronan-mediated Angiogenesis That Is implicated in Tumor Progression*

R. Salgia, Frances E. Lennon, P. Singleton, 2014, The Journal of Biological Chemistry.

Tumor Progression Hyaluronan-mediated Angiogenesis That Is the Low Molecular Weight forKinase Ephrin Receptor A 2 Is Required Transactivation of the Receptor-tyrosine Molecular Bases of Disease :

R. Salgia, Frances E. Lennon, P. Singleton, 2014 .

HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression

R. Salgia, Frances E. Lennon, P. Singleton, 2015, Front. Oncol..

Hyaluronic Acid Binding Protein 2 Is a Novel Regulator of Vascular Integrity

Frances E. Lennon, J. Garcia, P. Singleton, 2010, Arteriosclerosis, thrombosis, and vascular biology.

The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer

R. Salgia, Frances E. Lennon, J. Moss, 2014, PloS one.

Acute Lung Injury Regulation by Hyaluronan.

Frances E. Lennon, P. Singleton, 2011, Journal of allergy & therapy.

Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Frances E. Lennon, P. Singleton, 2011, American journal of physiology. Lung cellular and molecular physiology.

Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.

R. Farré, D. Gozal, Frances E. Lennon, 2014, American journal of respiratory and critical care medicine.

The &mgr;-Opioid Receptor in Cancer Progression: Is There a Direct Effect?

Frances E. Lennon, J. Moss, P. Singleton, 2012, Anesthesiology.

Extracellular Vesicles from Caveolin-Enriched Microdomains Regulate Hyaluronan-Mediated Sustained Vascular Integrity

Frances E. Lennon, P. Singleton, V. Poroyko, 2015, International journal of cell biology.

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma

R. Salgia, Frances E. Lennon, H. Kindler, 2016, Scientific Reports.

The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression: A Laboratory Investigation

Chin-Tu Chen, R. Salgia, Frances E. Lennon, 2011, Anesthesia and analgesia.

Overexpression of the &mgr;-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis

R. Salgia, Frances E. Lennon, J. Moss, 2012, Anesthesiology.

Overexpression of the -Opioid Receptor in Human Non- Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis

R. Salgia, Frances E. Lennon, J. Moss, 2012 .

Opioid Regulation of Vascular Integrity

Frances E. Lennon, P. Singleton, 2013 .

sheep mucociliary dysfunction in allergic Hyaluronan blocks porcine pancreatic

Frances E. Lennon, P. Singleton, W. Abraham, 2015 .

Review Article Hyaluronan regulation of vascular integrity

Frances E. Lennon, P. Singleton, 2011 .

Hyaluronan regulation of vascular integrity.

Frances E. Lennon, P. Singleton, 2011, American journal of cardiovascular disease.

High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness.

Frances E. Lennon, J. Garcia, Yurong Guo, 2010, American journal of physiology. Lung cellular and molecular physiology.

Engagement of CD 44 modulates cyclooxygenase induction , VEGF generation , and cell proliferation in human vascular endothelial cells

Joseph F. Murphy, Frances E. Lennon, D. Fitzgerald, 2004 .

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

R. Bueno, R. Salgia, Frances E. Lennon, 2014, PloS one.

FAK and paxillin, two potential targets in pancreatic cancer

S. Batra, R. Salgia, Frances E. Lennon, 2016, Oncotarget.

Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics

V. Bindokas, R. Salgia, Frances E. Lennon, 2013, Cancer biology & therapy.

EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation*

R. Salgia, Frances E. Lennon, E. Vokes, 2010, The Journal of Biological Chemistry.

Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and cell proliferation in human vascular endothelial cells

Joseph F. Murphy, Frances E. Lennon, D. Fitzgerald, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells

S. Batra, Prakash Kulkarni, R. Salgia, 2019, Journal of clinical medicine.

Mitochondrial dynamics: biology and therapy in lung cancer

R. Salgia, Frances E. Lennon, 2014, Expert Opinion on Investigational Drugs.

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

R. Bueno, R. Salgia, Frances E. Lennon, 2014, PloS one.

High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness.

Frances E. Lennon, Yurong Guo, P. Singleton, 2010, American journal of physiology. Lung cellular and molecular physiology.